Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

diagnostics

  • Home
  •  
  • diagnostics



  • Most Read
  • Latest Comments
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • Lumos Diagnostics expands FebriDx distribution to Belgium
    Lumos Diagnostics expands FebriDx distribution to Belgium
    • News

  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    Lumos Diagnostics partners with Apatek to create rare disorder test for newborns

    Phenylketonuria. Most people won’t know what it is, let alone how to say it, let alone spell it. But for the few who do, they know it’s a serious birth defect that can have devastating effects.  Also known as PKU, phenylketonuria is a very rare, congenital disorder that causes a build up of amino acid

    Read More
    Public
  • Theranos, but make it legit.. Does this company have the answer to cancer detection via blood test?
    • News

    Theranos, but make it legit.. Does this company have the answer to cancer detection via blood test?

    Treating cancer is a primary goal of many biotech companies, but for any treatment to begin, physicians need a definitive diagnosis. We know that time is critical in disease diagnosis and initiating treatment sooner translates to better patient outcomes more often than not. The field of diagnostics is the yin to medical treatment’s yang. They

    Read More
    Public
  • 4DMedical to compete with fairy bread for best Aussie invention
    • News

    4DMedical to compete with fairy bread for best Aussie invention

    Australians are a smart bunch. Although the pavlova is disputed, we gladly claim awesome inventions like the black box flight recorder, spray-on skin, the cochlear implant, plastic money and fairy bread (arguably the greatest invention of them all). Whilst I’m not sure much could compete with fairy bread, 4DMedical (ASX: 4DX) are giving it a

    Read More
    Public
  • 4DMedical’s clinical pilot program to progress following successful first phase
    • News

    4DMedical’s clinical pilot program to progress following successful first phase

    Following a particularly well received first phase of their clinical pilot program, medical technology company 4DMedical (ASX: 4DX) is advancing their respiratory imaging platform to Phase 2 of their clinical pilot program. Conducted with Australia’s leading medical imaging provider, I-MED Radiology Network, Phase 1 of the program saw radiologists use 4DMedical’s proprietary XV Lung Ventilation

    Read More
    Public
  • Curing sickness with viruses: How Imugene is using oncolytic viruses to treat cancer
    • News

    Curing sickness with viruses: How Imugene is using oncolytic viruses to treat cancer

    Despite the many advances in cancer therapy, we still haven’t quite hit the nail on the head, with cancer still responsible for 12% of all deaths worldwide each year.  The advancement of cancer therapies and the growing body of research is impressive to say the least, yet cancer patients of today do not fare much

    Read More
    Public
  • IPO Watch: Lumos to accelerate decentralised healthcare diagnostics with $187m float
    • News

    IPO Watch: Lumos to accelerate decentralised healthcare diagnostics with $187m float

    With ever increasing bodies of medical research and demand for early disease detection climbing, it’s high time that we rethink diagnostic testing. The trend of having to wait three days to see if your pee is free of nasties is fraught with administration challenges and can delay treatment. Spend time in any medical establishment and

    Read More
    Public
  • 1
  • 2
  • 3
  • 4
  • 5

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.